| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $18.1M | +99.4% |
| Cost of Revenue | $18.7M | +45.8% |
| Gross Profit | -$660K | +82.6% |
| R&D Expense | $85.4M | -16.8% |
| SG&A Expense | $34.8M | +4.7% |
| Operating Income | -$127.6M | +19.4% |
| Pre-tax Income | -$145.1M | +4.6% |
| Income Tax | $308K | +80.1% |
| Net Income | -$145.4M | +4.5% |
| EPS (Basic) | -$2.55 | +10.5% |
| EPS (Diluted) | -$2.55 | +10.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $72.3M | +150.5% |
| Short-term Investments | $49.6M | -40.3% |
| Accounts Receivable | $3.4M | +183.3% |
| Inventory | $5.8M | +146.8% |
| Current Assets | $153.5M | +24.5% |
| Total Assets | $179.7M | +21.8% |
| Current Liabilities | $35.9M | -8.4% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$115.1M | -7.6% |
| Capital Expenditures | $4.6M | -9.8% |
| Investing Cash Flow | $29.9M | -69.4% |
| Financing Cash Flow | $128.6M | — |
| Free Cash Flow | -$119.7M | -6.8% |
| $166.5M |
| +245.9% |
| Stockholders' Equity | $13.2M | -86.7% |